Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on April 15, 2025
Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates
GlobeNewswire
·
April 15, 2025
WARRINGTON, Pa., April 15, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions, today reported …
Chemomab Announces New Medical and Clinical Appointments
GlobeNewswire
·
April 15, 2025
David M. Weiner, MD, Rejoins Chemomab as Interim Chief Medical Officer, Bringing Extensive Biotechnology and Pharmaceutical Industry R…
TransGlobal Assets Inc. (OTC: TMSH) and The Now Corporation (OTC: NWPN) Strike Strategic Deal to Commercialize Acclaimed Works by Michael Berman
GlobeNewswire
·
April 15, 2025
Strategic IP Partnership Expands Literary Works into Multimedia: TransGlobal Assets Inc. (OTC: TMSH), through Mindwell Solutions Group, has signed an exclusive global media rights deal with The Now Corporation (OTC: NWPN) to adapt and commercialize the …
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones
GlobeNewswire
·
April 15, 2025
REDWOOD CITY, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy to preserve sight for life in highly prevalent ocular diseases, today reported financial …
Atsena Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy Designation for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis
GlobeNewswire
·
April 15, 2025
DURHAM, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that the U.S. Food and Drug …
Zions Bancorporation to Implement nCino Platform and Intelligent Solutions as the Technology Foundation of its Lending End-to-End Process Transformation
GlobeNewswire
·
April 15, 2025
WILMINGTON, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced that Zions Bancorporation has selected nCino as its technology platform as they digitally …
Dyne Therapeutics Announces Chief Business Officer and Chief Scientific Officer Appointments
GlobeNewswire
·
April 15, 2025
- Vikram Ranade, PhD, appointed as chief business officer - - Ranjan Batra, PhD, appointed as chief scientific officer - - Oxana Beskrovnaya, PhD, transitioning to chief innovation officer - WALTHAM, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Dyne …
Mawson Infrastructure Group Inc. Announces Participation in Upcoming Conferences and Events
GlobeNewswire
·
April 15, 2025
MIDLAND, Pa., April 15, 2025 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ: MIGI) ("Mawson" or "the Company"), a publicly-traded technology company focused on digital infrastructure platforms for artificial intelligence (AI), high- …
Fortrea Announces Date for First Quarter 2025 Financial Results and Conference Call
GlobeNewswire
·
April 15, 2025
DURHAM, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its first quarter 2025 financial results before the market opens on Monday, …
Axonius Appoints Former Disney CISO Ryan Knisley as Chief Product Strategist
GlobeNewswire
·
April 15, 2025
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Axonius, the leader in cyber asset management that delivers visibility and actionability across all digital assets, today announced the appointment of Ryan Knisley as Chief Product Strategist. Knisley brings …
Remix Therapeutics Appoints Linda C. Bain to Board of Directors
GlobeNewswire
·
April 15, 2025
WATERTOWN, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced the …
Foghorn Therapeutics to Host Virtual Investor Event to Review Pipeline Updates in Conjunction with 2025 AACR Annual Meeting
GlobeNewswire
·
April 15, 2025
Company to share new preclinical combination data for FHD-909 (LY4050784), a potential first-in-class selective SMARCA2 inhibitor, with non-small cell lung cancer (NSCLC) as the primary target population Additional updates include new preclinical data for …
Accelerating the Adoption of AI Solutions for the Enterprise - Climb Channel Solutions and Unframe Sign Global Distribution Partnership
GlobeNewswire
·
April 15, 2025
-Fresh from a $50M round of investment, Unframe is now eyeing North America and EMEA growth- -Partnership with Climb will enable resellers and enterprises to access Unframe’s platform and deliver cutting-edge AI solutions at scale- EATONTOWN, N.J., April …
Surge Copper Evaluates Energy-Saving HPGR Technology for Berg Project
GlobeNewswire
·
April 15, 2025
Vancouver, British Columbia, April 15, 2025 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to highlight results from an industrial energy efficiency study investigating the …
SANTO TOMAS PROJECT PRESENTATION
GlobeNewswire
·
April 15, 2025
VANCOUVER, Canada, April 15, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO, OTC: ORRCF) (“Oroco” or the “Company”). Last week Oroco presented at the Mexican Discoveries 2025 Conference to update the Mexico resource sector on our corporate …
Skye Bioscience Demonstrates Over 30% Weight Loss with Nimacimab and Tirzepatide Combination in Preclinical Model
GlobeNewswire
·
April 15, 2025
Nimacimab shows comparable weight loss to monlunabant and tirzepatide alone, and an additive effect in combination with tirzepatide, in diet-induced obesity model New in vitro data demonstrates superior potency of nimacimab’s differentiated and favorable …
Xanadu Mines Ltd Results of Extraordinary General Meeting
GlobeNewswire
·
April 15, 2025
TORONTO, April 15, 2025 (GLOBE NEWSWIRE) -- (ASX: XAM, TSX: XAM) (Xanadu or the Company) advises that as required by ASX Listing Rule 3.13.2 and Section 251AA of the Corporations Act 2001 (Cth), the results of Xanadu Mines Ltd’s Extraordinary General …
Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit
GlobeNewswire
·
April 15, 2025
HUNTSVILLE, AL, April 15, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, announced that Randall Moreadith, M. …
TRX Gold Reports Second Quarter 2025 Results
GlobeNewswire
·
April 15, 2025
TORONTO, April 15, 2025 (GLOBE NEWSWIRE) -- TRX Gold Corporation (TSX: TRX) (NYSE American: TRX) (the “Company” or “TRX Gold”) reported its results for the second quarter of 2025 (“Q2 2025”) for the three and six months ended February 28, 2025. Financial …
First Atlantic Nickel Reports DTR Metallurgical Results from RPM Hole 2: Magnetic Concentrate of 1.32% Nickel & 1.95% Chromium Over Entire 216 Meter Drill Hole
GlobeNewswire
·
April 15, 2025
VANCOUVER, British Columbia, April 15, 2025 (GLOBE NEWSWIRE) -- First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) ("First Atlantic" or the "Company") is pleased to announce Davis Tube Recovery (DTR) metallurgical test results from drill …